ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-18V1462
Home | Market Reports | Health| Reproductive Health
Global Hypoactive Sexual Desire Disorder HSDD Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-18V1462
Report
December 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AMAG Pharmaceuticals
Allergan plc
Ivix LLX
EndoCeutics
Emotional Brain BV
S1 Biopharma, Inc.
Sprout Pharmaceuticals Inc.

Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Hypoactive Sexual Desire Disorder (HSDD) Treatment Market

Hypoactive Sexual Desire Disorder (HSDD) Treatment Market

Hypoactive sexual desire disorder (HSDD) is the absence of sexual thoughts and fantasies causing low libido and sex drive in women population worldwide.
Market Analysis and Insights: Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
The global Hypoactive Sexual Desire Disorder (HSDD) Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Hypoactive Sexual Desire Disorder (HSDD) Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Hypoactive Sexual Desire Disorder (HSDD) Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hypoactive Sexual Desire Disorder (HSDD) Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hypoactive Sexual Desire Disorder (HSDD) Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Hypoactive Sexual Desire Disorder (HSDD) Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Hypoactive Sexual Desire Disorder (HSDD) Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Report

Report Metric Details
Report Name Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AMAG Pharmaceuticals, Allergan, Plc., Ivix LLX, EndoCeutics, Inc., Emotional Brain BV, S1 Biopharma, Inc., Sprout Pharmaceuticals, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Hypoactive Sexual Desire Disorder (HSDD) Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hypoactive Sexual Desire Disorder (HSDD) Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hypoactive Sexual Desire Disorder (HSDD) Treatment revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report?

Ans: The main players in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market are AMAG Pharmaceuticals, Allergan, Plc., Ivix LLX, EndoCeutics, Inc., Emotional Brain BV, S1 Biopharma, Inc., Sprout Pharmaceuticals, Inc.

What are the Application segmentation covered in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report?

Ans: The Applications covered in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report?

Ans: The Types covered in the Hypoactive Sexual Desire Disorder (HSDD) Treatment Market report are Buspirone, Bupropion, Testosterone, Flibanserin, Bremelanotide, Cognitive Behavior Therapy

Recommended Reports

Sexual Dysfunction Drugs

Hormonal and Fertility

Mental Health Treatments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Buspirone
1.2.3 Bupropion
1.2.4 Testosterone
1.2.5 Flibanserin
1.2.6 Bremelanotide
1.2.7 Cognitive Behavior Therapy
1.3 Market by Application
1.3.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Perspective (2019-2030)
2.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Trends by Region
2.2.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Region (2019-2024)
2.2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Region (2025-2030)
2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Dynamics
2.3.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Industry Trends
2.3.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
2.3.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
2.3.4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hypoactive Sexual Desire Disorder (HSDD) Treatment by Players
3.1.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Players (2019-2024)
3.1.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hypoactive Sexual Desire Disorder (HSDD) Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio
3.4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2023
3.5 Global Key Players of Hypoactive Sexual Desire Disorder (HSDD) Treatment Head office and Area Served
3.6 Global Key Players of Hypoactive Sexual Desire Disorder (HSDD) Treatment, Product and Application
3.7 Global Key Players of Hypoactive Sexual Desire Disorder (HSDD) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Type
4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Type (2019-2024)
4.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2025-2030)
5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Application
5.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Application (2019-2024)
5.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2019-2030)
6.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
6.2.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024)
6.2.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2025-2030)
6.2.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2019-2030)
6.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
6.3.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024)
6.3.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2025-2030)
6.3.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2019-2030)
6.4 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
6.4.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024)
6.4.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2019-2030)
7.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
7.2.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024)
7.2.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2025-2030)
7.2.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2019-2030)
7.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
7.3.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024)
7.3.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2025-2030)
7.3.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2019-2030)
7.4 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
7.4.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024)
7.4.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2019-2030)
8.2 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
8.2.1 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024)
8.2.2 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2025-2030)
8.2.3 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2019-2030)
8.3 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
8.3.1 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024)
8.3.2 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2025-2030)
8.3.3 China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2019-2030)
9.2 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
9.2.1 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024)
9.2.2 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2025-2030)
9.2.3 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2019-2030)
9.3 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
9.3.1 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024)
9.3.2 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2025-2030)
9.3.3 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2019-2030)
9.4 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region
9.4.1 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2019-2024)
9.4.3 Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AMAG Pharmaceuticals
11.1.1 AMAG Pharmaceuticals Company Details
11.1.2 AMAG Pharmaceuticals Business Overview
11.1.3 AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.1.4 AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
11.1.5 AMAG Pharmaceuticals Recent Developments
11.2 Allergan, Plc.
11.2.1 Allergan, Plc. Company Details
11.2.2 Allergan, Plc. Business Overview
11.2.3 Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.2.4 Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
11.2.5 Allergan, Plc. Recent Developments
11.3 Ivix LLX
11.3.1 Ivix LLX Company Details
11.3.2 Ivix LLX Business Overview
11.3.3 Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.3.4 Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
11.3.5 Ivix LLX Recent Developments
11.4 EndoCeutics, Inc.
11.4.1 EndoCeutics, Inc. Company Details
11.4.2 EndoCeutics, Inc. Business Overview
11.4.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.4.4 EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
11.4.5 EndoCeutics, Inc. Recent Developments
11.5 Emotional Brain BV
11.5.1 Emotional Brain BV Company Details
11.5.2 Emotional Brain BV Business Overview
11.5.3 Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.5.4 Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
11.5.5 Emotional Brain BV Recent Developments
11.6 S1 Biopharma, Inc.
11.6.1 S1 Biopharma, Inc. Company Details
11.6.2 S1 Biopharma, Inc. Business Overview
11.6.3 S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.6.4 S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
11.6.5 S1 Biopharma, Inc. Recent Developments
11.7 Sprout Pharmaceuticals, Inc.
11.7.1 Sprout Pharmaceuticals, Inc. Company Details
11.7.2 Sprout Pharmaceuticals, Inc. Business Overview
11.7.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
11.7.4 Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
11.7.5 Sprout Pharmaceuticals, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
AMAG Pharmaceuticals
Allergan plc
Ivix LLX
EndoCeutics
Emotional Brain BV
S1 Biopharma, Inc.
Sprout Pharmaceuticals Inc.
List of Tables
    Table 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Buspirone
    Table 3. Key Players of Bupropion
    Table 4. Key Players of Testosterone
    Table 5. Key Players of Flibanserin
    Table 6. Key Players of Bremelanotide
    Table 7. Key Players of Cognitive Behavior Therapy
    Table 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 9. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2019-2024)
    Table 12. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2025-2030)
    Table 14. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Trends
    Table 15. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
    Table 16. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
    Table 17. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
    Table 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Share by Players (2019-2024)
    Table 20. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2023)
    Table 21. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Industry Ranking 2022 VS 2023 VS 2024
    Table 22. Global 5 Largest Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Global Key Players of Hypoactive Sexual Desire Disorder (HSDD) Treatment, Headquarters and Area Served
    Table 24. Global Key Players of Hypoactive Sexual Desire Disorder (HSDD) Treatment, Product and Application
    Table 25. Global Key Players of Hypoactive Sexual Desire Disorder (HSDD) Treatment, Product and Application
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2019-2024)
    Table 29. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2025-2030)
    Table 31. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Share by Application (2019-2024)
    Table 33. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Share by Application (2025-2030)
    Table 35. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 36. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 37. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 38. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 39. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 41. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 43. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 44. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 45. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 46. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 49. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 50. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 51. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 52. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 54. Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 55. Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 56. Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 57. Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 58. Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2019-2024) & (US$ Million)
    Table 59. Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 65. Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2025-2030) & (US$ Million)
    Table 67. AMAG Pharmaceuticals Company Details
    Table 68. AMAG Pharmaceuticals Business Overview
    Table 69. AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 70. AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)
    Table 71. AMAG Pharmaceuticals Recent Developments
    Table 72. Allergan, Plc. Company Details
    Table 73. Allergan, Plc. Business Overview
    Table 74. Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 75. Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)
    Table 76. Allergan, Plc. Recent Developments
    Table 77. Ivix LLX Company Details
    Table 78. Ivix LLX Business Overview
    Table 79. Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 80. Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)
    Table 81. Ivix LLX Recent Developments
    Table 82. EndoCeutics, Inc. Company Details
    Table 83. EndoCeutics, Inc. Business Overview
    Table 84. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 85. EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)
    Table 86. EndoCeutics, Inc. Recent Developments
    Table 87. Emotional Brain BV Company Details
    Table 88. Emotional Brain BV Business Overview
    Table 89. Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 90. Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)
    Table 91. Emotional Brain BV Recent Developments
    Table 92. S1 Biopharma, Inc. Company Details
    Table 93. S1 Biopharma, Inc. Business Overview
    Table 94. S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 95. S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)
    Table 96. S1 Biopharma, Inc. Recent Developments
    Table 97. Sprout Pharmaceuticals, Inc. Company Details
    Table 98. Sprout Pharmaceuticals, Inc. Business Overview
    Table 99. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 100. Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024) & (US$ Million)
    Table 101. Sprout Pharmaceuticals, Inc. Recent Developments
    Table 102. Research Programs/Design for This Report
    Table 103. Key Data Information from Secondary Sources
    Table 104. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type: 2023 VS 2030
    Figure 3. Buspirone Features
    Figure 4. Bupropion Features
    Figure 5. Testosterone Features
    Figure 6. Flibanserin Features
    Figure 7. Bremelanotide Features
    Figure 8. Cognitive Behavior Therapy Features
    Figure 9. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2023 VS 2030
    Figure 11. Hospitals Case Studies
    Figure 12. Clinic Case Studies
    Figure 13. Others Case Studies
    Figure 14. Hypoactive Sexual Desire Disorder (HSDD) Treatment Report Years Considered
    Figure 15. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region: 2023 VS 2030
    Figure 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players in 2023
    Figure 19. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2023
    Figure 21. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2019-2030)
    Figure 23. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2019-2030)
    Figure 24. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2019-2030)
    Figure 25. United States Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2019-2030)
    Figure 29. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2019-2030)
    Figure 30. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2019-2030)
    Figure 31. Germany Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2019-2030)
    Figure 39. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2019-2030)
    Figure 40. Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2019-2030)
    Figure 42. Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2019-2030)
    Figure 43. Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2019-2030)
    Figure 44. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2019-2030)
    Figure 54. Brazil Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. AMAG Pharmaceuticals Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
    Figure 61. Allergan, Plc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
    Figure 62. Ivix LLX Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
    Figure 63. EndoCeutics, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
    Figure 64. Emotional Brain BV Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
    Figure 65. S1 Biopharma, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
    Figure 66. Sprout Pharmaceuticals, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Female Sexual Dysfunction Treatment Market Insights Forecast to 2030
Global Erectile Dysfunction Treatment Drugs Market Insights Forecast to 2030
Sexual Dysfunction Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Female Sexual Dysfunction Treatment Drug Market Research Report 2024
Global Male Hypogonadism Therapy Market Insights Forecast to 2030
Global Sexually Transmitted Diseases STD Treatment Market Research Report 2024
Global Sexually Transmitted Disease STD Testing Market Insights Forecast to 2030
Hormone Disorder Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Erectile Dysfunction Treatment Market Insights Forecast to 2030
Global Obsessive Compulsive Disorder Drugs Market Insights Forecast to 2030
Global Drugs for Sexual Dysfunction Market Research Report 2024
Global Obsessive Compulsive Disorder Medicine Market Research Report 2025
Global Sexually Transmitted Diseases STD Testing Market Insights Forecast to 2030
Global Polycystic Ovary Syndrome Treatment Market Insights Forecast to 2030
Global Genital Herpes Treatment Drugs Market Insights Forecast to 2030
Hypoactive Sexual Desire Disorder Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anxiety Disorders Treatment Market Insights Forecast to 2030
Global Hyperpigmentation Disorder Treatment Market Insights Forecast to 2030
Global Hypogonadism Treatment Market Research Report 2025
Global Sexually Transmitted Disease Therapeutics Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions